INTRODUCTION
============

The risk of developing lymphomas is greatly increased in HIV infected patients. AIDS associated lymphomas are characterized by their rapid progression, frequent extranodal initial manifestations and poor outcome.1 The incidence of extranodal non- Hodgkin\'s lymphomas (NHL) in HIV/AIDS patients is 3%; soft tissue involvement is rare and is described only in 0.1% of the cases.1 In this article, we reviewed the epidemiological, clinical, histopathological, immunological, virological and the outcome of four HIV/AIDS patients with soft tissue masses as clinical presentation of NHL.

CASE REPORT
===========

The patients were clinically staged according to the Ann Arbor system. Primary NHL of the soft tissue was defined as those lymphomas presenting with involvement of the soft tissue or the muscle as the predominant manifestation of the disease. Patients with cutaneous or bone tissue involvement were excluded. All diagnoses were performed by histopathological examination of biopsy smears obtained from the soft tissue masses. Histopathological diagnosis was made according to the criteria of the World Health Organization (WHO).^[@B02]^Immunohistochemical stains were applied in all cases. During an 11-year period analyzed in our hospital for infectious diseases, 92 HIV-infected patients were diagnosed with lymphoma. Sixty-six (72%) of them had NHL and 26 (28%) had Hodgkin\'s disease. Of 66 NHL, 41 (64%) were extranodal NHL and 4 (0.09%) were soft tissue primary NHL. All were males with a median of age of 41 years. Clinical presentation showed painless and large subcutaneous masses with rapidly increasing size. Two patients with history of intravenous drug use (IVDUs) had antibodies against hepatitis C virus (HCV) and the other 2 presented positive hepatitis B (HBV) serology. Lactate dehydrogenase (LDH) levels were elevated in the 4 patients and only one patient (25%) had evidence of bone marrow infiltration. Sites of involvement included the chest wall in all of them ([Figures 1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"}) with other masses in the upper leg and the scalp in two. Histopathological and immunophenotype studies revealed 2 plasmablastic lymphomas (PBL), 1 diffuse large B cell lymphoma (DLBCL) and 1 Burkitt lymphoma (BL). Two patients died after a short survival time following lymphoma diagnosis due to an aggressive and rapid clinical course of the neoplasm and disseminated tuberculosis, respectively, without the possibility of receiving chemotherapy because of his poor clinical status. One patient died 12 months later of unrelated cause and the other is alive. Demographic and clinical findings are summarized in [tables 1](#t01){ref-type="table"} and [2](#t02){ref-type="table"}.

![A large mass involving soft tissues in the chest wall, without compromising the skin or axillary lymphadenopathy](abd-88-0631-g01){#f01}

![A subcutaneous tumor located on the chest wall.](abd-88-0631-g02){#f02}

###### 

Demographic findings in four cases of soft tissue lymphomas from AIDS patients

  ----------------------------- ---------- ---------- ---------------------------- ----------------------------
                                **1**      **2**      **3**                        **4**
  **Gender**                    male       male       male                         male
  **Age**                       35         46         37                           48
  **HIV/risk infection**        IVDUs      IVDUs      Unprotected sexual contact   Unprotected sexual contact
  **Clinical Stage**            Advanced   Advanced   Advanced                     Advanced
  **HBV**                       (-)        (-)        (+)                          (+)
  **HCV**                       (+)        (+)        (-)                          (-)
  **LDH (U/L)**                 1280       786        926                          1518
  **Bone marrow involvement**   (+)        (-)        (-)                          (-)
  ----------------------------- ---------- ---------- ---------------------------- ----------------------------

###### 

Immunological, histopathological and virological findings from AIDS patients with soft tissue lymphomas

                             **1**                      **2**                                   **3**                       **4**
  -------------------------- -------------------------- --------------------------------------- --------------------------- ----------------------------------
  **Location**               Chest wall and upper leg   Chest wall                              Chest wall, scalp           Chest wall
  **CD4 level (cell/uL)**    37                         357                                     56                          201
  **Plasma Viral Load**      Detectable                 Undetectable                            Detectable                  Undetectable
  **Histological subtype**   Plasmablastic lymphoma     Diffuse large B cell lymphoma (DLBCL)   Plasmablastic lymphoma      Burkitt\'s lymphoma
  **Survival**               1 month                    6 months                                1 month                     12 months
  **Treatment**              None                       CHOP-R plus HAART                       none                        CHOP-R plus HAART
  **Response**               None                       Partial                                 None                        Partial
  **Cause of death**         Lymphoma progression       Alive                                   Disseminated tuberculosis   Sepsis with multiorganic failure

DISCUSSION
==========

The incidence of NHL including DLBCL, Burkitt\'s lymphoma and PBL is increased among HIVseropositive patients and 16% of deaths in AIDS patients have been associated with lymphomas.^[@B02]^The incidence of NHL in HIV patients is 3% and the lesions usually are of high-grade and with extranodal involvement as clinical presentation. About 70% of AIDS-associated lymphomas are NHL.^[@B01],[@B02]^The incidence of extranodal NHL of the soft tissues is low and account only for 0.1% of the cases.^[@B03],[@B04]^Soft tissue lymphomas at presentation are considered to be primary only if the staging procedures exclude other disease sites.^[@B03]^Soft tissue lymphomas include those masses that involve the subcutaneous and the musculoskeletal tissues; in our experience, these neoplasms are characterized by fast growth with frequent involvement of the adjacent tissues, such as the skin and bone ([Figure 3](#f03){ref-type="fig"}).^[@B03]^

![A large soft tissue mass involving the subcutaneous and musculoskeletal tissue on the chest wall. There is no evidence of regional nodal infiltration.](abd-88-0631-g03){#f03}

Salamao et al describes a clinic pathologic study of 19 patients who developed lymphomas as soft tissue masses without evidence of lymph node involvement.^[@B04]^The authors conclude that malignant lymphomas initially diagnosed in soft tissues are most commonly DLBCL. In contrast, 2 patients of our series had diagnosis of the histopathological subtype named as PBL. These are rare tumors occurring almost exclusively in the setting of HIV infection. PBL was recognized as a distinct entity, a subtype of DLBCL, in the World Health Organization (WHO) classification; one was a BL and the last was a DLBCL.^[@B05],[@B06]^

Cutaneous B-cell lymphomas have been also described in HIV patients as red skin nodules in the arms, head and trunk. These lesions usually start in the skin and may involve subcutaneous tissues.^[@B07]^

In our experience, ultrasound of musculoskeletal tissue provides valuable information about the extent of the mass.^[@B08],[@B09]^

Advanced neoplasm disease at presentation, bone marrow infiltration, prior diagnosis of AIDS and a poor performance status are associated with a shorter survival in HIV-patients associated NHL, as we can see in our series.^[@B10]^

Early excision biopsy is necessary to confirm the diagnosis of these neoplasms and to determine the histopathological subtype.

Chemotherapy and/or radi otherapy are the best therapeutic alternatives for NHL of the soft tissues; however, some authors have published a good clinical outcome in patients treated with a wide surgical excision followed by chemotherapy.^[@B09]^

The impact of highly active antiretroviral therapy (HAART) on NHL response and survival rates has been well demonstrated in several studies. Patients receiving HAART plus chemotherapy have a more significant opportunity to achieve complete remission.^[@B10]^In our series, the 2 patients treated with chemotherapy plus HAART had a partial clinical response.

Early diagnosis followed by chemotherapy plus HAART is necessary to achieve a good clinical outcome in this kind of patients.
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